Currently, siRNA, miRNA, piRNAs and other carriers can be effective tools for targeted FTH1 in the tumor (Balaratnam, West & Basu, 2018), of which H-ferritin siRNA has achieved initial success in improving the curative effect of gliomas in patients receiving chemotherapy (Liu et al., 2011). The gene discussed is FTH1; the disease is central nervous system cancer.